RYTM

Latest SEC Filings & News for RYTM

1 most recent filing and news item mentioning RYTM. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/RYTM/news?limit=20"

Pull RYTM filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsAug 4, 2026Positive

Rhythm Reports Q2 2026 Sales of $71.3M, Launching IMCIVREE for HO

Rhythm Pharmaceuticals reports second-quarter net product revenue of $71.3 million, up 19% sequentially, following the successful U.S. launch of IMCIVREE for acquired hypothalamic obesity. The company attributed the performance to increased demand for the treatment.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.